HIF1A and central nervous system cancer: Finally, RT-qPCR and western blotting revealed increasing levels of HIF1α in World Health Organization (WHO) grade II glioma to grade IV tumours, but no difference in HIF2α expression was observed (Fig. 1j and S1D).